Retrovirology (Sep 2012)

rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses

  • Bart P,
  • Huang Y,
  • Frahm N,
  • Karuna S,
  • Allen M,
  • Kochar NK,
  • Chappuis S,
  • Gaillard J,
  • Graham B,
  • Pantaleo G

DOI
https://doi.org/10.1186/1742-4690-9-S2-O72
Journal volume & issue
Vol. 9, no. Suppl 2
p. O72

Abstract

Read online

No abstracts available.